Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: A proposed circuit mechanism

Journal of Neuroscience

Volumn 17, Issue 21, 1997, Pages 8498-8505

  Abercrombie, Elizabeth D ^a   DeBoer, Peter ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acetylcholine; D amphetamine; Dopamine; Dopamine D1 receptor; GABA; In vivo microdialysis; Striatum; Substantia nigra

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE PROTEIN;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOPAMINE RELEASE; INTERNEURON; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA; ANIMAL; BIOLOGICAL MODEL; CORPUS STRIATUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; 2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACETYLCHOLINE; ANIMALS; BICUCULLINE; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INJECTIONS, INTRAPERITONEAL; INTERNEURONS; MALE; MICRODIALYSIS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 0030612009     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-21-08498.1997     Document Type: Article

References (9)

1. Abercrombie ED, Finlay JM (1991) Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC. In: Microdialysis in the neurosciences (Robinson TE, Justice Jr JB, eds), pp 253-274. Amsterdam: Eisevier.
2. Acquas E, Wilson C, Fibiger HC (1997) Nonstriatal dopamine Dl re-ceptors regulate striatal acetylcholine release in vivo. J Pharmaeol Exp Ther 281:360-368.
3. 2 dopamine receptors in rat striatum under freely moving conditions. Brain Res 518:193-198.
4. B receptors differentially regulate striatal acetylcholine release in vivo. Neurosci Lett 160:126-130.
5. 1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin, receptors. J Pharmaeol Exp Ther 269:1144-1151.
6. Anderson JJ, Kuo S, Chase TN (1994b) Endogenous excitatory amino acids tonically stimulate striatal acetylcholine release through NMDA but not AM PA receptors. Neurosci Lett 176:264-268.
7. 1C receptors in rat brain. J Pharmaeol Exp Ther 255:843-857.
8. 2 dopamine receptor agonist in rats. Pharmaeol Biochem Behav 29:89-92.
9. 1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome. J Recept Res 8:107-120.